| Zebrafish as a natural host model for Vibrio cholerae colonization and transmission DL Runft, KC Mitchell, BH Abuaita, JP Allen, S Bajer, K Ginsburg, ... Applied and environmental microbiology 80 (5), 1710-1717, 2014 | 129 | 2014 |
| Understanding the risk factors and long-term consequences of cisplatin-associated acute kidney injury: an observational cohort study ZY Bhat, P Cadnapaphornchai, K Ginsburg, M Sivagnanam, S Chopra, ... PLoS One 10 (11), e0142225, 2015 | 83 | 2015 |
| ERG/AKR1C3/AR constitutes a feed-forward loop for AR signaling in prostate cancer cells K Powell, L Semaan, MK Conley-LaComb, I Asangani, YM Wu, ... Clinical Cancer Research 21 (11), 2569-2579, 2015 | 81 | 2015 |
| Delayed radical prostatectomy is not associated with adverse oncologic outcomes: implications for men experiencing surgical delay due to the COVID-19 pandemic KB Ginsburg, GL Curtis, RE Timar, AK George, ML Cher The Journal of Urology 204 (4), 720-725, 2020 | 75 | 2020 |
| Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active surveillance DR Kaye, J Qi, TM Morgan, S Linsell, KB Ginsburg, BR Lane, JE Montie, ... BJU international 123 (5), 846-853, 2019 | 26 | 2019 |
| Risk of becoming lost to follow-up during active surveillance for prostate cancer KB Ginsburg, GB Auffenberg, J Qi, IJ Powell, SM Linsell, JE Montie, ... European urology 74 (6), 704-707, 2018 | 22 | 2018 |
| The impact of a statewide active surveillance initiative: a roadmap for increasing active surveillance utilization nationwide RA Vince Jr, Y Sun, B Mahal, K Ginsburg, A George, M Cher, B Lane, ... European urology 83 (4), 307-310, 2023 | 20 | 2023 |
| Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience. Letter. FD Gaylis, MR Cooperberg, RC Chen, J Malin, S Loeb, JS Witte, ... Journal of Urology 206 (1), 171-172, 2021 | 17 | 2021 |
| Avoidance of androgen deprivation therapy in radiorecurrent prostate cancer as a clinically meaningful endpoint for salvage cryoablation KB Ginsburg, A Elshafei, C Yu, JS Jones, ML Cher The Prostate 77 (14), 1446-1450, 2017 | 16 | 2017 |
| Association of surgical delay and overall survival in patients with T2 renal masses: implications for critical clinical decision-making during the COVID-19 pandemic KB Ginsburg, GL Curtis, DN Patel, WM Chen, MC Strother, A Kutikov, ... Urology 147, 50-56, 2021 | 15 | 2021 |
| Clinical Performance of Technetium-99m–Sestamibi SPECT/CT Imaging in Differentiating Oncocytic Tumors From Renal Cell Carcinoma in Routine Clinical Practice JP Schober, A Braun, KB Ginsburg, S Bell, AA Castro Bigalli, M Chen, ... The Journal of Urology 210 (3), 438-445, 2023 | 12 | 2023 |
| Impact of early confirmatory tests on upgrading and conversion to treatment in prostate cancer patients on active surveillance KB Ginsburg, JC Jacobs, J Qi, DR Kaye, SS Eggly, SM Linsell, ... Urology 147, 213-222, 2021 | 12 | 2021 |
| The impact of race and sex on metastatic bladder cancer survival A Mahran, A Miller, A Calaway, M Prunty, C Arenas-Gallo, I Isali, ... Urology 165, 98-105, 2022 | 11 | 2022 |
| Ischemia time has little influence on renal function following partial nephrectomy: is it time for urology to stop the tick-tock dance? KB Ginsburg, JP Schober, A Kutikov European Urology 81 (5), 501-502, 2022 | 11 | 2022 |
| Identification of oncological characteristics associated with improved overall survival in patients with adrenocortical carcinoma treated with adjuvant radiation therapy … KB Ginsburg, AA Chandra, JP Schober, EA Handorf, RG Uzzo, ... Urologic Oncology: Seminars and Original Investigations 39 (11), 791. e1-791. e7, 2021 | 11 | 2021 |
| Pathological and clinical outcomes in a large surveillance and intervention cohort of radiographically cystic renal masses RA Lee, RG Uzzo, J Anaokar, A Thomas, S Wei, BT Ristau, A McIntosh, ... The Journal of urology 209 (4), 686-693, 2023 | 10 | 2023 |
| Should all prostate needle biopsy Gleason score 4+ 4= 8 prostate cancers be high risk? Implications for shared decision-making and patient counselling K Ginsburg, AI Cole, ME Silverman, J Livingstone, DW Smith, LK Heilbrun, ... Urologic Oncology: Seminars and Original Investigations 38 (3), 78. e1-78. e6, 2020 | 10 | 2020 |
| The use and short-term outcomes of active surveillance in men with National Comprehensive Cancer Network favorable intermediate-risk prostate cancer: The initial Michigan … R Paudel, R Madan, J Qi, S Ferrante, ML Cher, BR Lane, AK George, ... Journal of Urology 209 (1), 170-179, 2023 | 8 | 2023 |
| Patient preferences and treatment decisions for prostate cancer: results from a statewide urological quality improvement collaborative R Paudel, S Ferrante, J Qi, RL Dunn, DL Berry, A Semerjian, CM Brede, ... Urology 155, 55-61, 2021 | 6 | 2021 |
| Confirmatory magnetic resonance imaging with or without biopsy impacts decision making in newly diagnosed favorable risk prostate cancer KB Ginsburg, R Arcot, J Qi, SM Linsell, DR Kaye, AK George, ML Cher The Journal of Urology 201 (5), 923-928, 2019 | 6 | 2019 |
